• 6308 Citations
  • 33 h-Index
1991 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

  • 6308 Citations
  • 33 h-Index
  • 118 Article
  • 6 Review article
  • 5 Letter
  • 1 Comment/debate
Filter
Article
2018

Durable treatment-free remission in patients with chronic myeloid leukemia in chronic phase following frontline nilotinib: 96-week update of the ENESTfreedom study

Ross, D. M., Masszi, T., Gómez Casares, M. T., Hellmann, A., Stentoft, J., Conneally, E., Garcia-Gutierrez, V., Gattermann, N., le Coutre, P. D., Martino, B., Saussele, S., Giles, F. J., Radich, J. P., Saglio, G., Deng, W., Krunic, N., Bédoucha, V., Gopalakrishna, P. & Hochhaus, A., May 1 2018, In : Journal of cancer research and clinical oncology. 144, 5, p. 945-954 10 p.

Research output: Contribution to journalArticle

41 Citations (Scopus)

Efficacy and safety of ruxolitinib after and versus interferon use in the RESPONSE studies

Kiladjian, J. J., Guglielmelli, P., Griesshammer, M., Saydam, G., Masszi, T., Durrant, S., Passamonti, F., Jones, M., Zhen, H., Li, J., Gadbaw, B., Perez Ronco, J., Khan, M. & Verstovsek, S., Apr 1 2018, In : Annals of Hematology. 97, 4, p. 617-627 11 p.

Research output: Contribution to journalArticle

9 Citations (Scopus)

Efficacy and Tolerability of a 2-Year Rituximab Maintenance Therapy in Patients with Advanced Follicular Lymphoma after Induction of Response with Rituximab-Containing First Line-Regimens (HUSOM Study)

Schneider, T., Rosta, A., Losonczy, H., Radványi, G., Ujj, G., Egyed, M., Illés, Á., Jakucs, J., Szerafin, L., Gasztonyi, Z., Masszi, T., Iványi, J., Demeter, J., Dombi, P., Tóth, A. & Borbényi, Z., Apr 1 2018, In : Pathology and Oncology Research. 24, 2, p. 199-205 7 p.

Research output: Contribution to journalArticle

2 Citations (Scopus)

Five-year PFS from the AETHERA trial of brentuximab vedotin for Hodgkin lymphoma at high risk of progression or relapse

Moskowitz, C. H., Walewski, J., Nademanee, A., Masszi, T., Agura, E., Holowiecki, J., Abidi, M. H., Chen, A. I., Stiff, P., Viviani, S., Bachanova, V., Sureda, A., McClendon, T., Lee, C., Lisano, J. & Sweetenham, J., Dec 20 2018, In : Blood. 132, 25, p. 2639-2642 4 p.

Research output: Contribution to journalArticle

30 Citations (Scopus)

High dose chemotherapy and autologous stem cell transplantation in nodular lymphocyte-predominant Hodgkin lymphoma: A retrospective study by the European society for blood and marrow transplantation-lymphoma working party

Akhtar, S., Montoto, S., Boumendil, A., Finel, H., Masszi, T., Jindra, P., Nemet, D., Fuhrmann, S., Beguin, Y., Castagna, L., Ferrara, F., Capria, S., Malladi, R., Moraleda, J. M., Bloor, A., Ghesquières, H., Meissner, J., Sureda, A. & Dreger, P., Jan 2018, In : American Journal of Hematology. 93, 1, p. 40-46 7 p.

Research output: Contribution to journalArticle

6 Citations (Scopus)

Impact of extramedullary disease in patients with newly diagnosed multiple myeloma undergoing autologous stem cell transplantation: A study from the chronic malignancies working party of the EBMT

Gagelmann, N., Eikema, D. J., Iacobelli, S., Koster, L., Nahi, H., Stoppa, A. M., Masszi, T., Caillot, D., Lenhoff, S., Udvardy, M., Crawley, C., Arcese, W., Mariette, C., Hunter, A., Leleu, X., Schipperus, M., Delforge, M., Pioltelli, P., Snowden, J. A., Itälä-Remes, M. & 4 others, Musso, M., van Biezen, A., Garderet, L. & Kröger, N., Apr 30 2018, In : Haematologica. 103, 5, p. 890-897 8 p.

Research output: Contribution to journalArticle

13 Citations (Scopus)

Patient-reported health-related quality of life from the phase III TOURMALINE-MM1 study of ixazomib-lenalidomide-dexamethasone versus placebo-lenalidomide-dexamethasone in relapsed/refractory multiple myeloma

Leleu, X., Masszi, T., Bahlis, N. J., Viterbo, L., Baker, B., Gimsing, P., Maisnar, V., Samoilova, O., Rosiñol, L., Langer, C., Song, K., Izumi, T., Cleeland, C., Berg, D., Lin, H. M., Zhu, Y., Skacel, T., Moreau, P. & Richardson, P. G., Aug 2018, In : American Journal of Hematology. 93, 8, p. 985-993 9 p.

Research output: Contribution to journalArticle

18 Citations (Scopus)

Sex-specific survival difference in association with HLA-DRB1∗04 following allogeneic haematopoietic stem cell transplantation for lymphoid malignancies

Balassa, K., Andrikovics, H., Remenyi, P., Batai, A., Szilvasi, A., Bors, A., Kiss, K. P., Rajczy, K., Inotai, D., Torbagyi, E., Lengyel, L., Barta, A., Gopcsa, L., Tordai, A. & Masszi, T., Jan 2018, In : Human Immunology. 79, 1, p. 13-19 7 p.

Research output: Contribution to journalArticle

Skin-homing CD8 + T cells preferentially express GPI-anchored peptidase inhibitor 16, an inhibitor of cathepsin K

Lupsa, N., Érsek, B., Horváth, A., Bencsik, A., Lajkó, E., Silló, P., Oszvald, Á., Wiener, Z., Reményi, P., Mikala, G., Masszi, T., Buzás, E. I. & Pós, Z., Dec 2018, In : European journal of immunology. 48, 12, p. 1944-1957 14 p.

Research output: Contribution to journalArticle

2 Citations (Scopus)

The adverse effect of FOPNL genomic variant is reversed by bortezomib-based treatment protocols in multiple myeloma

Kiss, K. P., Varga, G., Mikala, G., Balassa, K., Bors, A., Kovy, P., Meggyesi, N., Kozma, A., Csacsovszki, O., Remenyi, P., Valyi-Nagy, I., Tordai, A., Masszi, T. & Andrikovics, H., Mar 4 2018, In : Leukemia and Lymphoma. 59, 3, p. 710-716 7 p.

Research output: Contribution to journalArticle

2019

Calreticulin mutation specific CAL2 immunohistochemistry accurately identifies rare calreticulin mutations in myeloproliferative neoplasms

Mózes, R., Gángó, A., Sulák, A., Vida, L., Reiniger, L., Timár, B., Krenács, T., Alizadeh, H., Masszi, T., Gaál-Weisinger, J., Demeter, J., Csomor, J., Matolcsy, A., Kajtár, B. & Bödör, C., Apr 2019, In : Pathology. 51, 3, p. 301-307 7 p.

Research output: Contribution to journalArticle

2 Citations (Scopus)

Effectiveness of intra-arterial steroid administration for the treatment of steroid-refractory acute gastrointestinal graft-versus-host disease

Bérczi, V., Tóth, A., Tatai, G., Fábián, J., Reményi, P. & Masszi, T., Jan 1 2019, (Accepted/In press) In : Clinical Radiology.

Research output: Contribution to journalArticle

1 Citation (Scopus)

Impact of primary disease on outcome after allogeneic stem cell transplantation for transformed secondary acute leukaemia

on behalf of the Chronic Malignancies Working Party of the European Society for Blood Marrow Transplantation, May 2019, In : British Journal of Haematology. 185, 4, p. 725-732 8 p.

Research output: Contribution to journalArticle

2 Citations (Scopus)

Real-world data on the efficacy and safety of daratumumab treatment in Hungarian relapsed/refractory multiple myeloma patients

Lovas, S., Varga, G., Farkas, P., Masszi, T., Wohner, N., Bereczki, Á., Adamkovich, N., Borbényi, Z., Szomor, Á., Alizadeh, H., Szaleczky, E., Wolf, K., Schneider, T., Plander, M., Szendrei, T., Csacsovszki, O., Csukly, Z., Rajnics, P., Egyed, M., Nagy, Z. & 4 others, Rejtő, L., Illés, Á., Mikala, G. & Váróczy, L., Nov 1 2019, In : International Journal of Hematology. 110, 5, p. 559-565 7 p.

Research output: Contribution to journalArticle

2 Citations (Scopus)
2020

Analysis of data collected in the European Society for Blood and Marrow Transplantation (EBMT) Registry on a cohort of lymphoma patients receiving plerixafor

Sureda, A., Chabannon, C., Masszi, T., Pohlreich, D., Scheid, C., Thieblemont, C., Wahlin, B. E., Sakellari, I., Russell, N., Janikova, A., Dabrowska-Iwanicka, A., Touzeau, C., Esquirol, A., Jantunen, E., van der Werf, S., Bosman, P., Boumendil, A., Liu, Q., Celanovic, M., Montoto, S. & 1 others, Dreger, P., Mar 1 2020, In : Bone Marrow Transplantation. 55, 3, p. 613-622 10 p.

Research output: Contribution to journalArticle

2 Citations (Scopus)

Identification of the best-suited donor for generating virus-specific T cells

Tasnády, S., Karászi, É., Szederjesi, A., Bihari, G., Juhász, Z., Hardi, A., Kriván, G., Kállay, K., Reményi, P., Sinkó, J., Mikala, G., Réti, M. & Masszi, T., Jan 1 2020, In : Vox sanguinis. 115, 1, p. 18-26 9 p.

Research output: Contribution to journalArticle

Investigation of TGFB1 −1347C>T variant as a biomarker after allogeneic hematopoietic stem cell transplantation

Kövy, P., Meggyesi, N., Varga, L., Balassa, K., Bors, A., Gopcsa, L., Paksi, M., Bátai, Á., Vad, E., Sinkó, J., Tordai, A., Masszi, T., Reményi, P. & Andrikovics, H., Jan 1 2020, In : Bone Marrow Transplantation. 55, 1, p. 215-223 9 p.

Research output: Contribution to journalArticle

Results from a multicenter, noninterventional registry study for multiple myeloma patients who received stem cell mobilization regimens with and without plerixafor

Morris, C., Chabannon, C., Masszi, T., Russell, N., Nahi, H., Kobbe, G., Krejci, M., Auner, H. W., Pohlreich, D., Hayden, P., Basak, G. W., Lenhoff, S., Schaap, N., van Biezen, A., Knol, C., Iacobelli, S., Liu, Q., Celanovic, M., Garderet, L. & Kröger, N., Feb 1 2020, In : Bone Marrow Transplantation. 55, 2, p. 356-366 11 p.

Research output: Contribution to journalArticle

Open Access
1 Citation (Scopus)